RecruitingNot ApplicableNCT05724173

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Single Neuron Population Dynamics in Human Speech Motor Cortex for a Speech Prosthesis

Sponsor

Leigh R. Hochberg, MD, PhD.

Enrollment

3 participants

Start Date

Oct 18, 2023

Study Type

INTERVENTIONAL

Conditions

Anarthria Amyotrophic Lateral Sclerosis Spinal Cord Injuries Dysarthria locked-in Syndrome Muscular Dystrophies Brain Stem Infarctions tetraplegia

Summary

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called BrainGate Neural Interface System for people with amyotrophic lateral sclerosis, anarthria, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.